Skip to content

Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare Professionals

Sero-prevalence of Pertussis Antibodies and Disease Awareness Among Healthcare Professionals in Spain

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01706224
Enrollment
757
Registered
2012-10-15
Start date
2012-11-30
Completion date
2013-05-31
Last updated
2014-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pertussis

Keywords

Pertussis antibodies, Bordetella pertussis, sero-prevalence, Healthcare professionals (HCP), Spain

Brief summary

This study aims to determine the sero-prevalence of anti-pertussis antibodies among healthcare professionals at hospital centres in Spain.

Interventions

PROCEDUREBlood sample

Samples will be tested to determine the presence of anti-pertussis antibodies.

OTHERData collection

Electronic Case Report Forms (eCRF)

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Written informed consent obtained from the subject. * Subjects who the investigator believes that they can and will comply with the requirements of the protocol. * Male and female healthcare professionals aged ≥18 years from selected hospitals. * Healthcare professionals in frequent contact with patients in the hospitals. * Agreeing for collection of a blood sample for the study.

Exclusion criteria

• Medical students working as healthcare professionals.

Design outcomes

Primary

MeasureTime frame
Evaluation of the overall sero-prevalence of Bordetella pertussis infection among subjects with respect to anti-pertussis (anti-PT) antibody levels.Day 0 of each subject at the time of enrollment.
Evaluation of the overall sero-prevalence of Bordetella pertussis infection among subjects with respect to anti-PT seropositivity status.Day 0 of each subject at the time of enrollment.
Evaluation of the overall sero-prevalence of Bordetella pertussis infection among subjects with respect to anti-PT seronegativity status.Day 0 of each subject at the time of enrollment.

Secondary

MeasureTime frameDescription
Description of the knowledge and beliefs about whooping cough and vaccination against pertussis among healthcare professionals.Day 0 of each subject at the time of enrollment.
Evaluation of the sero-prevalence of B. pertussis antibodies among healthcare professionals aged ≥ 18 years.Day 0 of each subject at the time of enrollment.By age and gender, by type of healthcare professional, by hospital department of the healthcare professional, duration of service and time spent with patients.
Description of the household composition of healthcare professionals to identify the proportion of healthcare professionals potentially at a higher risk of contracting and transmitting pertussis.Day 0 of each subject at the time of enrollment.
Evaluation of the sero-prevalence of anti-pertussis antibodies among healthcare professionals by vaccination history.Day 0 of each subject at the time of enrollment.
Evaluation of the sero-prevalence of anti-pertussis antibodies among healthcare professionals by previous history of pertussis.Day 0 of each subject at the time of enrollment.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026